Search Results for 'aortic stenosis'
-
Cardiovascular
Medtronic's Evolut FX+ TAVR OK'ed for Severe Aortic Stenosis
Evolut FX+ has larger coronary access windows due to a modified, diamond-shaped frame design.Sam Brusco, Associate Editor 03.27.24
-
Cardiovascular
egnite Research Shows Untreated Aortic Stenosis Deadly at All Severity Levels
The research looked at a large cohort of AS patients over a four-year span.Charles Sternberg, Associate Editor 10.27.23
-
Bicuspid Aortic Stenosis Treatment to Create Huge Market Potential for TAVR Devices
Up to 53 percent of adult patients with diagnosed severe aortic stenosis are estimated to have bicuspid valve anatomy.Michael Barbella, Managing Editor 02.18.21
-
Cardiovascular
Medtronic Releases Evolut Low Risk Bicuspid Study Results
Low rates of paravalvular leak, high survival observed in late-breaking clinical trial.GlobeNewswire 03.30.20
-
JenaValve Technology Closes $50 Million Financing
Equity Round led by Bain Capital Life SciencesBusiness Wire 03.16.20
-
Cardiovascular
CE Mark for Abbott’s FlexNav Delivery System for TAVI Valve
The system improves control and delivery of the Portico TAVI valve even in complex clinical cases.PR Newswire 03.05.20
-
Cardiovascular
Getting to the Heart of the Matter: An Examination of Transcatheter Heart Technologies
Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.Sam Brusco, Associate Editor 03.04.20
-
Cardiovascular
Robocath Carries Out First Successful Human Robotic Coronary Angioplasties
R-One assists interventional cardiologists in performing coronary angioplasties.Robocath 11.04.19
-
Two Medical Device Executives Join JenaValve Executive Team
The pair bring a half century of experience in regulatory affairs and operational excellence to the company.Business Wire 10.31.19
-
Cardiovascular | Surgical
Admedus Turns Focus to TAVR Market
The company sold its CardioCel and VascuCel business to LeMaitre Vascular for up to $24.9MGlobalData 10.23.19
-
Cardiovascular | Surgical
FDA Approves Medtronic's Evolut PRO+ TAVR System
Improved functionality across four valve sizes and lowest delivery profile on market, Evolut PRO+ TAVR System launches in U.S. as TAVR patient population grows.GlobeNewswire 09.23.19
-
Cardiovascular
The TAVR Plot Thickens
Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.Sam Brusco, Associate Editor 09.06.19
-
Cardiovascular
Sapien 3 TAVR Receives FDA Approval for Low-Risk Patients
Now available for all patients diagnosed with severe, symptomatic aortic stenosis.Edwards Lifesciences Corporation 08.19.19
-
Cardiovascular
Medtronic Evolut TAVR System Gains Approval for Expanded Indications
System approved for low risk patients.Medtronic plc 08.19.19
-
Cardiovascular
First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Trial
Trial subjects enrolled in Harrisburg, Pa.Medtronic plc 04.01.16
